Randomized Phase II Trial of Total Gut Decontamination Followed by Fecal Microbiota Transplant (FMT), FMT-Alone or Standard of Care for Reduction in Acute Graft-Versus-Host Disease of the Gastrointestinal Tract in Patients Given Broad-Spectrum Antibiotics
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Nystatin (Primary) ; Piperacillin/tazobactam (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
Most Recent Events
- 02 Mar 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 21 Jan 2020 Planned initiation date changed from 1 Dec 2019 to 1 Jun 2020.
- 13 Aug 2019 Planned initiation date changed from 21 May 2019 to 1 Dec 2019.